Hayashi Masami 林正美

… Alternative Names

HAYASHI Masami 林正美

Less

Researcher Number	00551748
Other IDs
Affiliation (Current)	2023: 大阪医科薬科大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2021 – 2023: 大阪医科薬科大学, 医学部, 准教授 2018 – 2020: 大阪医科大学, 医学部, 准教授 2014 – 2017: 大阪医科大学, 医学部, 講師 2012 – 2015: 大阪医科大学, 医学部, 助教 2011: Osaka University, 医学(系)研究科(研究院), 助教 2009 – 2010: Osaka University, 医学系研究科, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related Except Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator 子宮頚癌 / マイクロRNA / miRNA / 卵巣癌 / 抗癌剤耐性 / Akt / mTOR / c-myc / MYCBP / c-Myc … More / exosome / エクソソーム / 癌 / 子宮頸癌 / 癌免疫治療 … More Except Principal Investigator 卵巣癌 / EMT / CD24 / 高分子ミセル / BNCT / 子宮頸癌 / 子宮内膜癌 / Met / 上皮間葉形態転換 / 婦人科悪性腫瘍 / 抗がん剤 / 抗癌剤 / MET / 癌関連繊維芽細胞 / 子宮体がん / 肥満 / 脂肪細胞 / 細胞外小胞 / オルガノイド / HGF / ABC transporter / ﾐｾﾙ / Foretinib / ミセル / 血管内皮障害 / フィブラート / 一酸化窒素 / TC療法 / 動脈硬化 / 血管内皮機能 / 明細胞腺癌 / ＡＭＨ / AMH: 146 T>G / -482 A>G / IVS1+149 T>A / IVS5-6 C>T / ＡＭＨＲ / 抗ミュウラー管ホルモン / 子宮内膜症 / 不妊 / 体外受精 / 一塩基多型 / ＳＮＰ / AMH　１４６T>G / AMHRII+１４９　T>A / ISV10+77　A>G / ISV５−６　C>T / Genotyping assay / ドラッグデリバリー / 腹膜播種転移 / 薬剤耐性 / 卵巣がん / drug delivery system / E-cadherin / Snail / colony formation / シスプラチン耐性 / シスプラチン / 耐性 / 早期発見 / 卵巣毒性 / アルキル化剤 / 顆粒膜細胞 / テストステロン / AMH / 卵巣保護 / GPR30 / EMT現象 / 不育症 / ES細胞 / 血管内皮前駆細胞 / 妊娠高血圧腎症モデルマウス / 流産モデルマウス / iPS細胞 / 子宮胎盤形成不全症 / 胎盤形成不全 / 骨髄由来内皮前駆細胞 / 不育症マウス / 流産マウス / 流産 / 妊娠高血圧症候群 / 妊娠高血圧腎症 / EPC / 子宮内胎児発育不全 / 妊娠高血圧腎症腎症 / 胎盤 / miRNA / 浸潤・転移 / mi RNA / エキソソーム / 癌関連線維芽細胞 / 子宮体癌 / lipid raft / 化学療法抵抗性 / ＣＤ２４ / ＥＭＴ / ＧＰＩアンカー型タンパク質 / ラフト形成 / 婦人科癌 / ＧＰＩアンカー型蛋白質 / 腫瘍随伴マクロファージ / FABP4 / がん関連繊維芽細胞 / がん / アディポカイン / がん微小環境 / 癌幹細胞 / ドラッグデリバリーシステム / 上皮・間葉形態転換 / ニッチ / Endothelinー2 / 子宮頸がん / 硼素化合物 / 硼素内包高分子ミセル / 難治性卵巣癌 / エリブリン / 腫瘍免疫 / 免疫応答 / T細胞 / ＰＤＸ / 臨床腫瘍直接移植モデル / EVｓ / 腫瘍直接移植モデル / Te-EVs / PDX / エクソソーム / 再発 / 硼素中性子捕捉療法 / LAT-1 / 同時化学放射線療法 / 癌免疫 Less

MPA抵抗性子宮体癌のレドックス機構に着目した妊孕能温存に向けた新規治療の開発Principal Investigator
- Principal Investigator
  
  林正美
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
卵巣癌再発・転移に対して硼素中性子捕捉療法の有用性の検討
- Principal Investigator
  
  恒遠啓示
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
硼素中性子捕捉療法とLAT1を介した化学療法を併用する子宮頸癌の新たな治療戦略
- Principal Investigator
  
  寺田信一
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
癌特異的EVs内のmiRNAをターゲットとした腫瘍免疫システムの機序解明
- Principal Investigator
  
  田中智人
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
卵巣癌オルガノイドを用いた脂肪細胞によるがん浸潤・転移機構の解明
- Principal Investigator
  
  佐々木浩
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築
- Principal Investigator
  
  大道正英
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
複合的癌免疫治療による子宮頚癌治療の革新的開発Principal Investigator
- Principal Investigator
  
  林正美
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Analysis of extracellular vesicles using patient derived xenograft
- Principal Investigator
  
  田中智人
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Target therapy of ovarian cancer including immunotherapy via Eribulin
- Principal Investigator
  
  FUJIWARA SATOE
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Research for cancer microenvironment via FABP4 in endometrial cnacer
- Principal Investigator
  
  Sasaki Hiroshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Treatment strategy of boron neutron capture therapy in cervical cancer
- Principal Investigator
  
  Tsunetoh Satoshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
The New therapy of placental insufficiency ~ Endothelial progenitor cells for angiojenesis and new anticoagulant therapy
- Principal Investigator
  
  Kanki Kazuyoshi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- Principal Investigator
  
  Terai Yoshito
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kobe University
  Osaka Medical College
activation regulatory mechanism of cancer fibroblast by obesity
- Principal Investigator
  
  Takai Masaaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel approach for cervical cancer using exosomePrincipal Investigator
- Principal Investigator
  
  Hayashi Masami
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer
- Principal Investigator
  
  Tanaka Yoshimichi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity
- Principal Investigator
  
  Tanabe Akiko
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer
- Principal Investigator
  
  Fujiwara Satoe
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analyzing the possible involvement of anti-Müllerian hormon and anti-Müllerian hormon receptor II single nucleotide polymorphism in infertility
- Principal Investigator
  
  Yamashita Yoshiki
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Potential therapeutic target of microRNA in cervical cancer.Principal Investigator
- Principal Investigator
  
  Masami Hayashi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells
- Principal Investigator
  
  TERAI YOSHITO
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.
- Principal Investigator
  
  TANABE Akiko
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.
- Principal Investigator
  
  TSUNETOH Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
子宮頸癌に対するC-myc結合蛋白を標的とした分子標的治療の可能性の検討Principal Investigator
- Principal Investigator
  
  林正美
- Project Period (FY)
  2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka University
Analysis of anticancer drug-resistant ovarian cancer cells under hypoxic tumor microenvironmentPrincipal Investigator
- Principal Investigator
  
  HAYASHI Masami
- Project Period (FY)
  2009 – 2010
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka University

All 2021 2020 2019 2018 2017 2015 2014 2011 2010 2009

All Journal Article Presentation

[Journal Article] Serum Exosomal microRNA-34a as a Potential Biomarker in Epithelial Ovarian Cancer2021
- Author(s)
  Maeda K, Sasaki H, Ueda S, Miyamoto S, Terada S, Konishi H, Kogata Y, Ashihara K, Fujiwara S, Tanaka Y, Tanaka T, Hayashi M, Ito Y, Kondo Y, Ochiya T, Ohmichi M
- Journal Title
  
  J Ovarian Res
  
  Volume: 13 Pages: 47-47
- DOI
  10.1186/s13048-020-00648-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-16K10482, KAKENHI-PROJECT-17K11303
[Journal Article] The Protective Effect of Testosterone on the Ovarian Reserve During Cyclophosphamide Treatment2020
- Author(s)
  Yoo M, Tanaka T, Konishi H, Tanabe A, Taniguchi K, Komura K, Hayashi M, Ohmichi M.
- Journal Title
  
  Onco Targets Ther
  
  Volume: 13 Pages: 2987-2995
- DOI
  10.2147/ott.s242703
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09838
[Journal Article] Pharmacokinetic Evaluation and Antitumor Potency of Liposomal Nanoparticle Encapsulated Cisplatin Targeted to CD24-positive Cells in Ovarian Cancer2020
- Author(s)
  Ashihara K, Terai Y, Tanaka T, Tanaka Y, Fujiwara S, Maeda K, Tunetoh S, Sasaki H, Hayashi M, Ohmichi M.
- Journal Title
  
  Oncol Lett
  
  Volume: 19 Pages: 1872-1880
- DOI
  10.3892/ol.2020.11279
- NAID
  120006873100
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-17K11304
[Journal Article] Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer2018
- Author(s)
  Kogata Y, Tanaka T,Ono Y, Hayashi M, Terai Y, Ohmichi M.
- Journal Title
  
  Oncotarget
  
  Volume: 9 Pages: 22769-22784
- DOI
  10.18632/oncotarget.25232
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-16K11165
[Journal Article] Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency ? The leading cause of preeclampsia2018
- Author(s)
  Sano Takumi、Terai Yoshito、Daimon Atsushi、Nunode Misa、Nagayasu Yoko、Okamoto Atsuko、Fujita Daisuke、Hayashi Masami、Ohmichi Masahide
- Journal Title
  
  Placenta
  
  Volume: 65 Pages: 1-6
- DOI
  10.1016/j.placenta.2018.03.006
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11165
[Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways2017
- Author(s)
  Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: - Pages: 3189-3200
- DOI
  10.3892/or.2017.5583
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
[Journal Article] Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines.2015
- Author(s)
  Ono YJ, Tanabe A, Tanaka T, Tanaka Y, Hayashi M, Terai Y, Ohmichi M.
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 14 Pages: 2353-2363
- DOI
  10.1158/1535-7163.mct-15-0187
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] Analysis of the methylation rate of the androgen receptor promoter region in granulosa cells in moderate to severe endometriosis patients undergoing controlled ovarian hyperstimulation2015
- Author(s)
  Yoko Nakamura, M.D., Yoshiki Yamashita, M.D., Natsuho Saito, M.D., Hikaru Yamamoto M.D., Masami Hayashi, M.D. Yoshito Terai, M.D., Masahide Ohmichi, M.D.
- Journal Title
  
  Journal of Reproductive Endocrinology & Infertility
  
  Volume: 1 Pages: 1-5
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25462581
[Journal Article] Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.2015
- Author(s)
  Michihiko Nakamura, Yoshihiro J Ono, Masanori Kanemura, Tomohito Tanaka, Masami Hayashi, Yhoshito Terai, Masahide Ohmichi
- Journal Title
  
  Gynecologic Oncology
  
  Volume: 139 Pages: 345-354
- DOI
  10.1016/j.ygyno.2015.08.010
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462620, KAKENHI-PROJECT-25670709
[Journal Article] Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum.2015
- Author(s)
  Ono YJ, Hayashi M, Tanabe A, Hayashi A, Kanemura M, Terai Y, Ohmichi M.
- Journal Title
  
  American Journal of Physiology-Endocrinology and Metabolism
  
  Volume: Apr 7
- DOI
  10.1152/ajpendo.00573.2014
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24390384, KAKENHI-PROJECT-25462619, KAKENHI-PROJECT-25462620, KAKENHI-PROJECT-25670709
[Journal Article] Analyzing the possible involvement of anti-Müllerian hormone and anti-Müllerian hormone receptor II single nucleotide polymorphism in infertility.2014
- Author(s)
  Yoko Yoshida, Yoshiki Yamashita, Atushi Hayashi,
- Journal Title
  
  Journal of assisted reproduction and genetics
  
  Volume: 2 Pages: 163-168
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462581
[Journal Article] Decorin induced by progesterone plays a crucial role in suppressing endometriosis.2014
- Author(s)
  Ono YJ, Terai Y, Tanabe A, Hayashi A, Hayashi M, Yamashita Y, Kyo S, Ohmichi
- Journal Title
  
  J Endocrinol
  
  Volume: 223 Pages: 203-216
- DOI
  10.1530/joe-14-0393
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24390384
[Journal Article] Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells.2011
- Author(s)
  Hayashi M, Yoo YG, Christensen J, Huang LE.
- Journal Title
  
  Cell Cycle. in press
- Data Source
  KAKENHI-PROJECT-21890130
[Journal Article] Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.2010
- Author(s)
  Mabuchi S, Kawase C, Altomare DA, Morishige K, Hayashi M, Sawada K, Ito K, Terai Y, Nishio Y, Klein-Szanto AJ, Burger RA, Ohmichi M, Testa JR, Kimura T.
- Journal Title
  
  Mol Cancer Ther 9
  
  Pages: 2411-2422
- Data Source
  KAKENHI-PROJECT-21890130
[Journal Article] An essential role of the HIF-1alpha-c-Myc axis in malignant progression.2009
- Author(s)
  Yoo YG, Hayashi M, Christensen J, Huang LE.
- Journal Title
  
  Ann N Y Acad Sci. 1177
  
  Pages: 198-204
- Data Source
  KAKENHI-PROJECT-21890130
[Journal Article] mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.2009
- Author(s)
  Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, Tsujimoto M, Yamoto M, Klein-Szanto AJ, Schilder RJ, Ohmichi M, Testa JR, Kimura T.
- Journal Title
  
  Clin Cancer Res. 15
  
  Pages: 5404-5413
- Data Source
  KAKENHI-PROJECT-21890130
[Journal Article] mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.2009
- Author(s)
  Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, et al.
- Journal Title
  
  Clin Cancer Res. 15
  
  Pages: 5404-5413
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21890130
[Presentation] 卵巣明細胞癌に対する切除組織培養分泌エクソソームを用いた特異的腫瘍マーカーの開発2020
- Author(s)
  丸岡　寛、田中智人、小西莉奈、飯藤宰士、石川　渚、大瀧瑠璃、上田尚子、宮本瞬輔、寺田信一、小西博巳、林　正美、大道正英
- Organizer
  第72回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-19K09838
[Presentation] New approaches using exosome for cervical cancer treatment.2019
- Author(s)
  Hiromi Konishi, Masami Hayashi, Shinichi Terada, Kana Kokunai, Natsuho Nakamura, Sayaka Taga, Satoe Fujiwara, Hiroshi Sasaki, Yoshito Terai, Masahide Ohmichi
- Organizer
  第71回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K09791
[Presentation] MicroRNA-22を介した子宮頸癌の分子標的治療への応用2017
- Author(s)
  中村真由美、林正美、橋田宗祐、丸岡寛、小西博巳、前田和也、田中良道、佐々木浩、寺井義人、大道正英
- Organizer
  日本産婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K11164
[Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017
- Author(s)
  芦原敬允, 寺井義人, 土橋裕允, 藤原聡枝, 田中良道, 田中智人, 恒遠啓示, 佐々木浩, 林正美, 大道正英
- Organizer
  第69回日本産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11304

1. OHMICHI Masahide (10283764)

# of Collaborated Projects: 25 results

# of Collaborated Products: 15 results
2. TANAKA Yoshimichi (10625502)

# of Collaborated Projects: 22 results

# of Collaborated Products: 10 results
3. TSUNETOH Satoshi (70388255)

# of Collaborated Projects: 20 results

# of Collaborated Products: 2 results
4. TERAI Yoshito (90278531)

# of Collaborated Projects: 20 results

# of Collaborated Products: 12 results
5. TANABE Akiko (70454543)

# of Collaborated Projects: 15 results

# of Collaborated Products: 4 results
6. Sasaki Hiroshi (80432491)

# of Collaborated Projects: 15 results

# of Collaborated Products: 6 results
7. Fujiwara Satoe (90707960)

# of Collaborated Projects: 15 results

# of Collaborated Products: 5 results
8. 田中智人 (90411363)

# of Collaborated Projects: 9 results

# of Collaborated Products: 2 results
9. KANEMURA Masanori (40298782)

# of Collaborated Projects: 8 results

# of Collaborated Products: 2 results
10. Yoo Saha (80625674)

# of Collaborated Projects: 8 results

# of Collaborated Products: 0 results
11. YAMASHITA Yoshiki (50268207)

# of Collaborated Projects: 4 results

# of Collaborated Products: 3 results
12. 古形祐平 (80829953)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
13. Hayashi Atushi (80411338)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
14. 寺田信一 (60861242)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
15. YAMADA Takashi (10182536)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. ASAHI Michio (10397614)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. Kanki Kazuyoshi (30770911)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. Takai Masaaki (90770933)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 藤田太輔 (90411371)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 鈴木裕介 (90770925)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 上田尚子 (70920148)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. 劉昌恵 (00849581)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. NAKAMURA Kiyoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. ITO Yuko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Hayashi Masami 林 正美

HAYASHI Masami 林 正美

Research Projects

Research Products

Co-Researchers

MPA抵抗性子宮体癌のレドックス機構に着目した妊孕能温存に向けた新規治療の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

複合的癌免疫治療による子宮頚癌治療の革新的開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Hayashi Masami 林正美

HAYASHI Masami 林正美